Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy.
about
Transfusion and coagulation management in liver transplantationAdvances in continuous renal replacement therapy: citrate anticoagulation update.Regional citrate anticoagulation for RRTs in critically ill patients with AKI.From the nephrologist's point of view: diversity of causes and clinical features of acute kidney injuryAdverse effects of α-ketoglutarate/malate in a rat model of acute kidney injury.Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysisCitrate shows protective effects on cardiovascular and renal function in ischemia-induced acute kidney injury.Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipmentDialysis and acute kidney injury: current evidence.Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome.Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.Prothrombotic State in a Patient With Acute Liver Failure: The Question of Anticoagulation.Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience.Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit
P2860
Q26995591-4798693B-D12E-400F-8029-738453D89426Q33403996-6A046F3E-0AEC-49D9-B8E2-492FCB0E8FE2Q34629661-EDD25411-65C7-4FB7-B46D-FE9891C6A8FAQ35891577-B876D78E-7A56-4330-AF3F-F3756DC64089Q36200293-0DE61966-A6CB-4D27-88D1-D95960825878Q36285489-358639A2-83F8-4645-933F-E90B06D03D80Q36342440-89DA3E13-230C-44C8-BF65-72734D6A98EEQ37212336-9488A6F3-87C0-4AE3-B2DA-7855644A37BEQ38187181-910735BC-5B8C-4E00-A882-4C0668472CA8Q46078253-0F9A46A2-7DB9-49BD-8FF2-72707224D7EEQ47150085-07921897-884A-4087-9428-0A4A208B418AQ47571298-F4640A07-AC94-4A46-B9BC-EDF5B88EA292Q50635510-61AC8227-DD11-4159-BD46-B0463211E485Q51018006-A56AB9CB-656E-4AD8-BD1F-9A8FA91EF75EQ59100879-BC9D7D8C-F873-4ECC-BE44-658A07AAD7F6
P2860
Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy and safety of regiona ...... ive renal replacement therapy.
@en
Efficacy and safety of regiona ...... ive renal replacement therapy.
@nl
type
label
Efficacy and safety of regiona ...... ive renal replacement therapy.
@en
Efficacy and safety of regiona ...... ive renal replacement therapy.
@nl
prefLabel
Efficacy and safety of regiona ...... ive renal replacement therapy.
@en
Efficacy and safety of regiona ...... ive renal replacement therapy.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of regiona ...... ive renal replacement therapy.
@en
P2093
Alexander Geis
Ali Canbay
Andreas Kribben
Andreas Paul
Christian Lösch
Fuat H Saner
Juergen W Treckmann
Oliver Witzke
Stephan Herget-Rosenthal
Thorsten Feldkamp
P2860
P304
P356
10.1093/NDT/GFR510
P407
P577
2011-11-01T00:00:00Z